Discover how the absence of a key regenerative protein in the kidneys can lead to acute injury through a process known as ferroptosis, shedding light on potential new avenues for treatment.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Loss of nephric augmenter of liver regeneration facilitates acute kidney injury via ACSL4-mediated ferroptosis.
Huang et al., J Cell Mol Med 2023
DOI: 10.1111/jcmm.18076
Study Highlights:
- New Findings: The study uncovers the role of augmenter of liver regeneration (ALR) in protecting against ferroptosis in acute kidney injury (AKI).
- Importance: This research provides insight into the mechanism by which ALR mitigates ferroptosis, a process linked to AKI, by interacting with long-chain-fatty-acid-CoA ligase 4 (ACSL4) and reducing harmful lipid accumulation.
- Contribution to Literature: The study adds to the understanding of AKI pathogenesis and suggests that targeting ALR could be a potential therapeutic strategy.
Results Summary:
The study demonstrated that ALR deficiency in a mouse model led to increased ferroptosis, reactive oxygen species (ROS) accumulation, and mitochondrial damage in AKI. Conversely, ALR overexpression reduced these effects. ALR was shown to bind directly to ACSL4, inhibiting its expression and consequently decreasing the levels of polyunsaturated fatty acids, particularly arachidonic acid. This interaction also reduced oxylipin accumulation, further protecting against ferroptosis in AKI.